$GHDX GENOMIC HEALTH INC Insider Trading Week 45/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENOMIC HEALTH INC in week 45/2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 22.98 | 3,576 | 82,176 | 56,424 | |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Option Exercise | M | 17.18 | 5,000 | 85,900 | 41,471 | |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 79.20 | 400 | 31,679 | 45,372 | 45.8 K to 45.4 K (-0.87 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 81.46 | 300 | 24,437 | 45,772 | 46.1 K to 45.8 K (-0.65 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 80.23 | 900 | 72,207 | 46,072 | 47 K to 46.1 K (-1.92 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 78.34 | 1,976 | 154,805 | 46,972 | 48.9 K to 47 K (-4.04 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 81.60 | 500 | 40,801 | 48,948 | 49.4 K to 48.9 K (-1.01 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 80.32 | 1,083 | 86,985 | 49,448 | 50.5 K to 49.4 K (-2.14 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 79.30 | 600 | 47,578 | 50,531 | 51.1 K to 50.5 K (-1.17 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Sell | S | 78.29 | 2,817 | 220,535 | 51,131 | 53.9 K to 51.1 K (-5.22 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 22.98 | 3,576 | 82,176 | 53,948 | 50.4 K to 53.9 K (+7.10 %) |
Nov 15 2018 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | CFO | Buy | M | 17.18 | 5,000 | 85,900 | 50,372 | 45.4 K to 50.4 K (+11.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 38,330 | 3,033,110 | 10,744,656 | 10.8 M to 10.7 M (-0.36 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 5,885 | 465,689 | 1,683,831 | 1.7 M to 1.7 M (-0.35 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 1,014 | 80,239 | 323,700 | 324.7 K to 323.7 K (-0.31 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 588 | 46,529 | 204,708 | 205.3 K to 204.7 K (-0.29 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 45 | 3,561 | 52,926 | 53 K to 52.9 K (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 657 | 51,989 | 223,855 | 224.5 K to 223.9 K (-0.29 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 3,296 | 263,978 | 10,782,986 | 10.8 M to 10.8 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 506 | 40,526 | 1,689,716 | 1.7 M to 1.7 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 87 | 6,968 | 324,714 | 324.8 K to 324.7 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 51 | 4,085 | 205,296 | 205.3 K to 205.3 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 4 | 320 | 52,971 | 53 K to 53 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 56 | 4,485 | 224,512 | 224.6 K to 224.5 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 53,013 | 4,244,714 | 10,786,282 | 10.8 M to 10.8 M (-0.49 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 8,139 | 651,684 | 1,690,222 | 1.7 M to 1.7 M (-0.48 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 1,403 | 112,337 | 324,801 | 326.2 K to 324.8 K (-0.43 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 814 | 65,176 | 205,347 | 206.2 K to 205.3 K (-0.39 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 62 | 4,964 | 52,975 | 53 K to 53 K (-0.12 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 908 | 72,703 | 224,568 | 225.5 K to 224.6 K (-0.40 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 99,280 | 7,752,428 | 10,839,295 | 10.9 M to 10.8 M (-0.91 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 15,242 | 1,190,194 | 1,698,361 | 1.7 M to 1.7 M (-0.89 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 2,628 | 205,211 | 326,204 | 328.8 K to 326.2 K (-0.80 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 1,524 | 119,004 | 206,161 | 207.7 K to 206.2 K (-0.73 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 115 | 8,980 | 53,037 | 53.2 K to 53 K (-0.22 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 1,702 | 132,903 | 225,476 | 227.2 K to 225.5 K (-0.75 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 15,014 | 1,220,038 | 10,938,575 | 11 M to 10.9 M (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 2,305 | 187,304 | 1,713,603 | 1.7 M to 1.7 M (-0.13 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 397 | 32,260 | 328,832 | 329.2 K to 328.8 K (-0.12 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 230 | 18,690 | 207,685 | 207.9 K to 207.7 K (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 18 | 1,463 | 53,152 | 53.2 K to 53.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 257 | 20,884 | 227,178 | 227.4 K to 227.2 K (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 46,511 | 3,774,912 | 10,953,589 | 11 M to 11 M (-0.42 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 7,140 | 579,495 | 1,715,908 | 1.7 M to 1.7 M (-0.41 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 1,231 | 99,910 | 329,229 | 330.5 K to 329.2 K (-0.37 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 714 | 57,949 | 207,915 | 208.6 K to 207.9 K (-0.34 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 54 | 4,383 | 53,170 | 53.2 K to 53.2 K (-0.10 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 796 | 64,605 | 227,435 | 228.2 K to 227.4 K (-0.35 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 7,533 | 606,473 | 11,000,100 | 11 M to 11 M (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 1,156 | 93,068 | 1,723,048 | 1.7 M to 1.7 M (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 199 | 16,021 | 330,460 | 330.7 K to 330.5 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 116 | 9,339 | 208,629 | 208.7 K to 208.6 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 9 | 725 | 53,224 | 53.2 K to 53.2 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 129 | 10,386 | 228,231 | 228.4 K to 228.2 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 11,877 | 954,711 | 11,007,633 | 11 M to 11 M (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 1,824 | 146,619 | 1,724,204 | 1.7 M to 1.7 M (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 314 | 25,240 | 330,659 | 331 K to 330.7 K (-0.09 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 182 | 14,630 | 208,745 | 208.9 K to 208.7 K (-0.09 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 14 | 1,125 | 53,233 | 53.2 K to 53.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 204 | 16,398 | 228,360 | 228.6 K to 228.4 K (-0.09 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 19,367 | 1,648,296 | 11,019,510 | 11 M to 11 M (-0.18 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 2,973 | 253,028 | 1,726,028 | 1.7 M to 1.7 M (-0.17 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 513 | 43,661 | 330,973 | 331.5 K to 331 K (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 297 | 25,277 | 208,927 | 209.2 K to 208.9 K (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 23 | 1,957 | 53,247 | 53.3 K to 53.2 K (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 332 | 28,256 | 228,564 | 228.9 K to 228.6 K (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 112,010 | 9,191,025 | 11,038,877 | 11.2 M to 11 M (-1.00 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 17,198 | 1,411,189 | 1,729,001 | 1.7 M to 1.7 M (-0.98 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 2,964 | 243,212 | 331,486 | 334.5 K to 331.5 K (-0.89 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 1,720 | 141,135 | 209,224 | 210.9 K to 209.2 K (-0.82 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 129 | 10,585 | 53,270 | 53.4 K to 53.3 K (-0.24 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 1,919 | 157,464 | 228,896 | 230.8 K to 228.9 K (-0.83 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 8,157 | 673,321 | 11,150,887 | 11.2 M to 11.2 M (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 1,252 | 103,347 | 1,746,199 | 1.7 M to 1.7 M (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 216 | 17,830 | 334,450 | 334.7 K to 334.5 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 125 | 10,318 | 210,944 | 211.1 K to 210.9 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 9 | 743 | 53,399 | 53.4 K to 53.4 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 140 | 11,556 | 230,815 | 231 K to 230.8 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 4,120 | 345,678 | 11,159,044 | 11.2 M to 11.2 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 633 | 53,110 | 1,747,451 | 1.7 M to 1.7 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 109 | 9,145 | 334,666 | 334.8 K to 334.7 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 63 | 5,286 | 211,069 | 211.1 K to 211.1 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 5 | 420 | 53,408 | 53.4 K to 53.4 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 71 | 5,957 | 230,955 | 231 K to 231 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 62,929 | 5,235,598 | 11,163,164 | 11.2 M to 11.2 M (-0.56 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 9,661 | 803,781 | 1,748,084 | 1.8 M to 1.7 M (-0.55 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 1,665 | 138,526 | 334,775 | 336.4 K to 334.8 K (-0.49 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 966 | 80,370 | 211,132 | 212.1 K to 211.1 K (-0.46 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 74 | 6,157 | 53,413 | 53.5 K to 53.4 K (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 1,078 | 89,688 | 231,026 | 232.1 K to 231 K (-0.46 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 17,602 | 1,511,565 | 11,226,093 | 11.2 M to 11.2 M (-0.16 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 2,702 | 232,033 | 1,757,745 | 1.8 M to 1.8 M (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 466 | 40,018 | 336,440 | 336.9 K to 336.4 K (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 270 | 23,186 | 212,098 | 212.4 K to 212.1 K (-0.13 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 21 | 1,803 | 53,487 | 53.5 K to 53.5 K (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 302 | 25,934 | 232,104 | 232.4 K to 232.1 K (-0.13 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 4,120 | 337,840 | 11,243,695 | 11.2 M to 11.2 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 633 | 51,906 | 1,760,447 | 1.8 M to 1.8 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 109 | 8,938 | 336,906 | 337 K to 336.9 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 63 | 5,166 | 212,368 | 212.4 K to 212.4 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 5 | 410 | 53,508 | 53.5 K to 53.5 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 71 | 5,822 | 232,406 | 232.5 K to 232.4 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 31.12 | 3,000 | 93,360 | 36,772 | |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 89.07 | 300 | 26,720 | 17,542 | 17.8 K to 17.5 K (-1.68 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 85.84 | 300 | 25,752 | 17,842 | 18.1 K to 17.8 K (-1.65 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 85.18 | 1,300 | 110,740 | 18,142 | 19.4 K to 18.1 K (-6.69 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 83.94 | 1,100 | 92,333 | 19,442 | 20.5 K to 19.4 K (-5.35 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 31.12 | 3,000 | 93,360 | 20,542 | 17.5 K to 20.5 K (+17.10 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 27.75 | 10,000 | 277,500 | 0 | |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 89.50 | 403 | 36,068 | 67,464 | 67.9 K to 67.5 K (-0.59 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 88.73 | 4,200 | 372,678 | 67,867 | 72.1 K to 67.9 K (-5.83 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 87.98 | 3,816 | 335,715 | 72,067 | 75.9 K to 72.1 K (-5.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 85.67 | 745 | 63,823 | 75,883 | 76.6 K to 75.9 K (-0.97 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Sell | S | 84.90 | 836 | 70,978 | 76,628 | 77.5 K to 76.6 K (-1.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 27.75 | 10,000 | 277,500 | 77,464 | 67.5 K to 77.5 K (+14.82 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 1,565 | 131,227 | 11,247,815 | 11.2 M to 11.2 M (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 240 | 20,124 | 1,761,080 | 1.8 M to 1.8 M (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 42 | 3,522 | 337,015 | 337.1 K to 337 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 24 | 2,012 | 212,431 | 212.5 K to 212.4 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 2 | 168 | 53,513 | 53.5 K to 53.5 K (0.00 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 27 | 2,264 | 232,477 | 232.5 K to 232.5 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 9,301 | 789,121 | 11,249,380 | 11.3 M to 11.2 M (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 1,428 | 121,155 | 1,761,320 | 1.8 M to 1.8 M (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 246 | 20,871 | 337,057 | 337.3 K to 337.1 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 143 | 12,132 | 212,455 | 212.6 K to 212.5 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 11 | 933 | 53,515 | 53.5 K to 53.5 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 159 | 13,490 | 232,504 | 232.7 K to 232.5 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 21,423 | 1,913,901 | 11,258,681 | 11.3 M to 11.3 M (-0.19 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 3,289 | 293,835 | 1,762,748 | 1.8 M to 1.8 M (-0.19 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 567 | 50,655 | 337,303 | 337.9 K to 337.3 K (-0.17 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 329 | 29,392 | 212,598 | 212.9 K to 212.6 K (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 25 | 2,233 | 53,526 | 53.6 K to 53.5 K (-0.05 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 367 | 32,787 | 232,663 | 233 K to 232.7 K (-0.16 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 30,555 | 2,601,670 | 11,280,104 | 11.3 M to 11.3 M (-0.27 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 4,692 | 399,510 | 1,766,037 | 1.8 M to 1.8 M (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 809 | 68,884 | 337,870 | 338.7 K to 337.9 K (-0.24 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 470 | 40,019 | 212,927 | 213.4 K to 212.9 K (-0.22 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 37 | 3,150 | 53,551 | 53.6 K to 53.6 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 522 | 44,447 | 233,030 | 233.6 K to 233 K (-0.22 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 36,174 | 3,102,970 | 11,310,659 | 11.3 M to 11.3 M (-0.32 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 5,554 | 476,417 | 1,770,729 | 1.8 M to 1.8 M (-0.31 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 957 | 82,091 | 338,679 | 339.6 K to 338.7 K (-0.28 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 555 | 47,607 | 213,397 | 214 K to 213.4 K (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 42 | 3,603 | 53,588 | 53.6 K to 53.6 K (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 620 | 53,183 | 233,552 | 234.2 K to 233.6 K (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 3,663 | 319,780 | 11,346,833 | 11.4 M to 11.3 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 562 | 49,063 | 1,776,283 | 1.8 M to 1.8 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 97 | 8,468 | 339,636 | 339.7 K to 339.6 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 56 | 4,889 | 213,952 | 214 K to 214 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 4 | 349 | 53,630 | 53.6 K to 53.6 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 63 | 5,500 | 234,172 | 234.2 K to 234.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 4,306 | 380,544 | 11,350,496 | 11.4 M to 11.4 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 661 | 58,416 | 1,776,845 | 1.8 M to 1.8 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 114 | 10,075 | 339,733 | 339.8 K to 339.7 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 66 | 5,833 | 214,008 | 214.1 K to 214 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 5 | 442 | 53,634 | 53.6 K to 53.6 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 74 | 6,540 | 234,235 | 234.3 K to 234.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 15,798 | 1,326,160 | 11,354,802 | 11.4 M to 11.4 M (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 2,425 | 203,566 | 1,777,506 | 1.8 M to 1.8 M (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 418 | 35,089 | 339,847 | 340.3 K to 339.8 K (-0.12 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 242 | 20,315 | 214,074 | 214.3 K to 214.1 K (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 18 | 1,511 | 53,639 | 53.7 K to 53.6 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 271 | 22,749 | 234,309 | 234.6 K to 234.3 K (-0.12 %) |